Found: 17
Select item for more details and to access through your institution.
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
- Published in:
- Cephalalgia, 2020, v. 40, n. 5, p. 470, doi. 10.1177/0333102419885905
- By:
- Publication type:
- Article
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Humanistic and economic burden of nausea and vomiting among migraine sufferers.
- Published in:
- Journal of Pain Research, 2017, v. 10, p. 689, doi. 10.2147/JPR.S124683
- By:
- Publication type:
- Article
First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125034
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciatica.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 1, p. 108, doi. 10.1111/bcp.12941
- By:
- Publication type:
- Article
From LBR-101 to Fremanezumab for Migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Capturing seizures in clinical trials of antiseizure medications for KCNQ2‐DEE.
- Published in:
- Epilepsia Open, 2021, v. 6, n. 1, p. 38, doi. 10.1002/epi4.12466
- By:
- Publication type:
- Article
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 11, p. 1145, doi. 10.1001/jamaneurol.2023.3542
- By:
- Publication type:
- Article
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 662, doi. 10.1111/head.14097
- By:
- Publication type:
- Article
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 10, p. 1743, doi. 10.1111/head.13654
- By:
- Publication type:
- Article
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 6, p. 880, doi. 10.1111/head.13534
- By:
- Publication type:
- Article
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 3, p. 383, doi. 10.1111/head.13446
- By:
- Publication type:
- Article
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 9, p. 1375, doi. 10.1111/head.13156
- By:
- Publication type:
- Article
A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
- Published in:
- Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 8, p. 1300, doi. 10.1111/head.12895
- By:
- Publication type:
- Article